# Efficacy of FLU-v in an H1N1 Influenza Human Challenge Model

> **NCT03180801** · PHASE2 · COMPLETED · sponsor: **PepTcell Limited** · enrollment: 153 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** adjuvanted FLU-v
- **BIOLOGICAL:** adjuvanted placebo
- **OTHER:** Influenza challenge

## Key facts

- **NCT ID:** NCT03180801
- **Lead sponsor:** PepTcell Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-18
- **Primary completion:** 2017-03-31
- **Final completion:** 2017-05-25
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2020-08-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03180801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03180801, "Efficacy of FLU-v in an H1N1 Influenza Human Challenge Model". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT03180801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*